These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33068816)

  • 21. Association of glutamate receptor gene polymorphisms with attention-deficit hyperactivity disorder susceptibility: a systematic review and meta-analysis.
    Zou D; Zeng Q; Liu P; Wei Y; Guo R; Zhu Y; He RR
    Front Genet; 2024; 15():1348387. PubMed ID: 38544802
    [No Abstract]   [Full Text] [Related]  

  • 22. MEF2C gene variations are associated with ADHD in the Chinese Han population: a case-control study.
    Fu X; Yao T; Chen X; Li H; Wu J
    J Neural Transm (Vienna); 2022 Apr; 129(4):431-439. PubMed ID: 35357565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between BDNF gene polymorphisms and attention deficit hyperactivity disorder in school-aged children in Wuhan, China.
    Luo L; Jiang X; Cao G; Xiong P; Yang R; Zhang J; Shen M
    J Affect Disord; 2020 Mar; 264():304-309. PubMed ID: 32056765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC6A1 gene involvement in susceptibility to attention-deficit/hyperactivity disorder: A case-control study and gene-environment interaction.
    Yuan FF; Gu X; Huang X; Zhong Y; Wu J
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():202-208. PubMed ID: 28442423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes.
    Elia J; Gai X; Xie HM; Perin JC; Geiger E; Glessner JT; D'arcy M; deBerardinis R; Frackelton E; Kim C; Lantieri F; Muganga BM; Wang L; Takeda T; Rappaport EF; Grant SF; Berrettini W; Devoto M; Shaikh TH; Hakonarson H; White PS
    Mol Psychiatry; 2010 Jun; 15(6):637-46. PubMed ID: 19546859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamatergic copy number variants and their role in attention-deficit/hyperactivity disorder.
    Akutagava-Martins GC; Salatino-Oliveira A; Genro JP; Contini V; Polanczyk G; Zeni C; Chazan R; Kieling C; Anselmi L; Menezes AM; Grevet EH; Bau CH; Rohde LA; Hutz MH
    Am J Med Genet B Neuropsychiatr Genet; 2014 Sep; 165B(6):502-9. PubMed ID: 24985920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome.
    Jacob CP; Weber H; Retz W; Kittel-Schneider S; Heupel J; Renner T; Lesch KP; Reif A
    J Psychiatr Res; 2013 Dec; 47(12):1902-8. PubMed ID: 24041656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Monoamine Oxidase A (MAOA) Gene uVNTR and rs6323 Polymorphisms with Attention Deficit and Hyperactivity Disorder in Korean Children.
    Hwang IW; Lim MH; Kwon HJ; Jin HJ
    Medicina (Kaunas); 2018 May; 54(3):. PubMed ID: 30344263
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of PIK3CG gene polymorphisms with attention-deficit/hyperactivity disorder: A case-control study.
    Gu X; Yuan FF; Huang X; Hou Y; Wang M; Lin J; Wu J
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():169-177. PubMed ID: 29097255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder].
    Kereszturi E; Király O; Csapó Z; Tárnok Z; Gádoros J; Sasvári-Székely M; Nemoda Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):11-8. PubMed ID: 17879560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association analyses of MAOA in Chinese Han subjects with attention-deficit/hyperactivity disorder: family-based association test, case-control study, and quantitative traits of impulsivity.
    Liu L; Guan LL; Chen Y; Ji N; Li HM; Li ZH; Qian QJ; Yang L; Glatt SJ; Faraone SV; Wang YF
    Am J Med Genet B Neuropsychiatr Genet; 2011 Sep; 156B(6):737-48. PubMed ID: 21761555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia.
    Ohtsuki T; Koga M; Ishiguro H; Horiuchi Y; Arai M; Niizato K; Itokawa M; Inada T; Iwata N; Iritani S; Ozaki N; Kunugi H; Ujike H; Watanabe Y; Someya T; Arinami T
    Schizophr Res; 2008 Apr; 101(1-3):9-16. PubMed ID: 18329248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.
    Hess C; Reif A; Strobel A; Boreatti-Hümmer A; Heine M; Lesch KP; Jacob CP
    J Neural Transm (Vienna); 2009 Feb; 116(2):121-30. PubMed ID: 18982239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress response genes associated with attention deficit hyperactivity disorder: A case-control study in Chinese children.
    Chen X; Wang M; Zhang Q; Hou Y; Huang X; Li S; Wu J
    Behav Brain Res; 2019 May; 363():126-134. PubMed ID: 30707907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of single nucleotide polymorphisms in the miR-183-96-182 cluster in adulthood attention-deficit and hyperactivity disorder (ADHD) and substance use disorders (SUDs).
    Sánchez-Mora C; Ramos-Quiroga JA; Garcia-Martínez I; Fernàndez-Castillo N; Bosch R; Richarte V; Palomar G; Nogueira M; Corrales M; Daigre C; Martínez-Luna N; Grau-Lopez L; Toma C; Cormand B; Roncero C; Casas M; Ribasés M
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1463-73. PubMed ID: 23906647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of GRM7 variants with different phenotype patterns of age-related hearing impairment in an elderly male Han Chinese population.
    Luo H; Yang T; Jin X; Pang X; Li J; Chai Y; Li L; Zhang Y; Zhang L; Zhang Z; Wu W; Zhang Q; Hu X; Sun J; Jiang X; Fan Z; Huang Z; Wu H
    PLoS One; 2013; 8(10):e77153. PubMed ID: 24146964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDH13 and LPHN3 Gene Polymorphisms in Attention-Deficit/Hyperactivity Disorder: Their Relation to Clinical Characteristics.
    Özaslan A; Güney E; Ergün MA; Okur İ; Yapar D
    J Mol Neurosci; 2021 Feb; 71(2):394-408. PubMed ID: 32691279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first evidence of an association between a polymorphism in the endocannabinoid-degrading enzyme FAAH (FAAH rs2295633) with attention deficit hyperactivity disorder.
    Ahmadalipour A; Mehdizadeh Fanid L; Zeinalzadeh N; Alizadeh M; Vaezi H; Hassanpour Aydinlou Z; Noorazar SG
    Genomics; 2020 Mar; 112(2):1330-1334. PubMed ID: 31377429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GAD1 gene polymorphisms are associated with hyperactivity in Attention-Deficit/Hyperactivity Disorder.
    Bruxel EM; Akutagava-Martins GC; Salatino-Oliveira A; Genro JP; Zeni CP; Polanczyk GV; Chazan R; Schmitz M; Rohde LA; Hutz MH
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1099-1104. PubMed ID: 27530595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association study of GRM7 polymorphisms and schizophrenia in the Chinese Han population.
    Niu W; Huang X; Yu T; Chen S; Li X; Wu X; Cao Y; Zhang R; Bi Y; Yang F; Wang L; Li W; Xu Y; He L; He G
    Neurosci Lett; 2015 Sep; 604():109-12. PubMed ID: 26254163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.